CCG258208
Overview:
A selective small molecules based upon a paroxetine to selectively inhibit G Protein-Coupled Receptor Kinase 2 (GRK2) for the treatment of heart failure.
A selective small molecules based upon a paroxetine to selectively inhibit G Protein-Coupled Receptor Kinase 2 (GRK2) for the treatment of heart failure.